Avalo Therapeutics, Inc. (AVTX) Earnings
|
Expand Research on AVTX
| Next EPS Date | 8/8/24 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +65.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/1/24 | Q423 | -$114.00 | N/A | N/A | $1.92M | $1M | N/A |  | | Details | |
11/9/23  |
Q323 | -$0.11 | -$1.10 | +$0.99 | $240K | $1M | N/A | | | Details | |
| 11/15/23 | Q323 | N/A | -$1.10 | N/A | N/A | $1M | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | N/A | -$0.80 | N/A | N/A | $500K | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | N/A | -$0.96 | N/A | N/A | $1M | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$0.77 | N/A | N/A | $4.26M | N/A | N/A | N/A | ||
| 3/15/23 | Q422 | N/A | -$0.77 | N/A | N/A | $4.26M | N/A | N/A | N/A | ||
| 3/20/23 | Q422 | N/A | -$0.77 | N/A | N/A | $4.26M | N/A | N/A | N/A |
